TCL Archive DCT To Renegotiate Cooperative Groups Term Of Award, Considering Other Major Changes March 4, 1988
TCL Archive NCI Advisors To Evaluate SPORE Program; Large Grants to Be Weighed Against R01s December 12, 1997
TCL Archive Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent September 30, 2011
TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
